Test Price
2,800 AED✅ Home Collection Available
GGCX Gene Analysis: Pseudoxanthoma Elasticum-like Disorder with Multiple Coagulation Factor Deficiency (NGS) in UAE
Executive Summary & Core Metrics
This NGS diagnostic test provides precise molecular identification of pathogenic variants in the GGCX gene associated with pseudoxanthoma elasticum-like disorder and multiple coagulation factor deficiency. Certified under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), the assay delivers 99.9% sensitivity and specificity for targeted variants.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by certified genetic counsellors.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced next-generation sequencing (NGS) test analyzes the entire coding sequence of the GGCX gene to identify pathogenic variants causing pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency. The test provides definitive molecular diagnosis for accurate clinical management, family screening, and early intervention.
| Feature | Our Test (NGS Clinical Grade) | Closest Alternative (Conventional PCR) |
|---|---|---|
| Precision | >99.9% sensitivity for single nucleotide variants & copy number changes | Limited to known hotspots; may miss novel or large deletions |
| Method | Next-Generation Sequencing + orthogonal confirmation | Sanger sequencing or targeted genotyping |
| Turnaround Time | 3–4 weeks (express options available) | Often 5–6 weeks due to sequential reflex testing |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that a confirmed pathogenic variant in GGCX must be correlated with the patient’s dermatological presentation, coagulation profile, and family history. This NGS test provides high-resolution molecular insight, but clinical evaluation and genetic counselling remain essential for appropriate management. Do not discontinue any prescribed medication without consulting your doctor.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory Note
⚠️ Important Safety Notice
Do not discontinue prescribed medication without consulting your doctor. Genetic testing may cause anxiety; professional genetic counselling is mandatory before and after testing. If you experience acute symptoms such as uncontrolled bleeding or severe skin changes, seek emergency care immediately.
Exclusion Criteria for Home Collection
- Active bleeding episode or known severe coagulopathy – consult physician first.
- Recent surgery or trauma within the past 2 weeks.
- Age under 18 without legal guardian consent.
Patient FAQ & Clinical Guidance
1. What does the GGCX gene test detect and why is it important?
This NGS test identifies pathogenic variants in the GGCX gene that cause pseudoxanthoma elasticum-like skin changes and deficiency of vitamin K-dependent clotting factors, enabling precise diagnosis. Early confirmation allows tailored dermatological surveillance, prophylactic coagulation factor management, and family cascade screening.
2. How is the sample collected and what is the process?
A certified phlebotomist visits your home for a simple blood draw, which is then transported in a cold-chain container to our ISO‑certified genomics laboratory. Alternatively, you may provide a dried blood spot on an FTA card; full pre‑instructions and genetic counselling are provided.
3. What do I do with the results and will insurance cover it?
Your results come with a comprehensive clinical interpretation; we arrange a tele‑consultation with a genetic counsellor who explains the findings in the context of your health. Many UAE insurers cover NGS panels for multisystem disorders—our billing team verifies coverage directly via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, stored securely, and handled in full compliance with these legal frameworks.
Clinical & Logistical Metadata
| Test Name | GGCX Gene Analysis (NGS) – Pseudoxanthoma Elasticum-like Disorder with Multiple Coagulation Factor Deficiency |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (express options available) |
| Sample Type / Matrix | Whole Blood (EDTA) or Dried Blood Spot on FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) of full coding region + orthogonal confirmation |
| ICD-10-CM Code | Q82.8, D68.8 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians